132 related articles for article (PubMed ID: 33786913)
1. Crystal structures of inhibitor complexes of M-PMV protease with visible flap loops.
Wosicki S; Kazmierczyk M; Gilski M; Zabranska H; Pichova I; Jaskolski M
Protein Sci; 2021 Jun; 30(6):1258-1263. PubMed ID: 33786913
[TBL] [Abstract][Full Text] [Related]
2. Comparison of a retroviral protease in monomeric and dimeric states.
Wosicki S; Gilski M; Zabranska H; Pichova I; Jaskolski M
Acta Crystallogr D Struct Biol; 2019 Oct; 75(Pt 10):904-917. PubMed ID: 31588922
[TBL] [Abstract][Full Text] [Related]
3. High-resolution structure of a retroviral protease folded as a monomer.
Gilski M; Kazmierczyk M; Krzywda S; Zábranská H; Cooper S; Popović Z; Khatib F; DiMaio F; Thompson J; Baker D; Pichová I; Jaskolski M
Acta Crystallogr D Biol Crystallogr; 2011 Nov; 67(Pt 11):907-14. PubMed ID: 22101816
[TBL] [Abstract][Full Text] [Related]
4. The RNA binding G-patch domain in retroviral protease is important for infectivity and D-type morphogenesis of Mason-Pfizer monkey virus.
Bauerová-Zábranská H; Stokrová J; Strísovsky K; Hunter E; Ruml T; Pichová I
J Biol Chem; 2005 Dec; 280(51):42106-12. PubMed ID: 16257973
[TBL] [Abstract][Full Text] [Related]
5. The G-patch domain of Mason-Pfizer monkey virus is a part of reverse transcriptase.
Křízová I; Hadravová R; Štokrová J; Günterová J; Doležal M; Ruml T; Rumlová M; Pichová I
J Virol; 2012 Feb; 86(4):1988-98. PubMed ID: 22171253
[TBL] [Abstract][Full Text] [Related]
6. Crystal structures of Aspergillus oryzae aspartic proteinase and its complex with an inhibitor pepstatin at 1.9A resolution.
Kamitori S; Ohtaki A; Ino H; Takeuchi M
J Mol Biol; 2003 Mar; 326(5):1503-11. PubMed ID: 12595261
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional structure of a monomeric form of a retroviral protease.
Veverka V; Bauerová H; Zábranský A; Lang J; Ruml T; Pichová I; Hrabal R
J Mol Biol; 2003 Oct; 333(4):771-80. PubMed ID: 14568536
[TBL] [Abstract][Full Text] [Related]
8. Crystallization and preliminary X-ray studies of dUTPase from Mason-Pfizer monkey retrovirus.
Barabás O; Németh V; Vértessy BG
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Apr; 62(Pt 4):399-401. PubMed ID: 16582495
[TBL] [Abstract][Full Text] [Related]
9. Cloning, bacterial expression, and characterization of the Mason-Pfizer monkey virus proteinase.
Hrusková-Heidingsfeldová O; Andreansky M; Fábry M; Bláha I; Strop P; Hunter E
J Biol Chem; 1995 Jun; 270(25):15053-8. PubMed ID: 7797487
[TBL] [Abstract][Full Text] [Related]
10. Role of Mason-Pfizer monkey virus CA-NC spacer peptide-like domain in assembly of immature particles.
Strohalmová-Bohmová K; Spiwok V; Lepšík M; Hadravová R; Křížová I; Ulbrich P; Pichová I; Bednárová L; Ruml T; Rumlová M
J Virol; 2014 Dec; 88(24):14148-60. PubMed ID: 25275119
[TBL] [Abstract][Full Text] [Related]
11. Nucleic Acid Binding by Mason-Pfizer Monkey Virus CA Promotes Virus Assembly and Genome Packaging.
Füzik T; Píchalová R; Schur FKM; Strohalmová K; Křížová I; Hadravová R; Rumlová M; Briggs JAG; Ulbrich P; Ruml T
J Virol; 2016 May; 90(9):4593-4603. PubMed ID: 26912613
[TBL] [Abstract][Full Text] [Related]
12. Integrase of Mason-Pfizer monkey virus.
Snásel J; Krejcík Z; Jencová V; Rosenberg I; Ruml T; Alexandratos J; Gustchina A; Pichová I
FEBS J; 2005 Jan; 272(1):203-16. PubMed ID: 15634344
[TBL] [Abstract][Full Text] [Related]
13. Effect of retroviral proteinase inhibitors on Mason-Pfizer monkey virus maturation and transmembrane glycoprotein cleavage.
Sommerfelt MA; Petteway SR; Dreyer GB; Hunter E
J Virol; 1992 Jul; 66(7):4220-7. PubMed ID: 1602542
[TBL] [Abstract][Full Text] [Related]
14. Luminometric method for screening retroviral protease inhibitors.
Horáková D; Rumlová M; Pichová I; Ruml T
Anal Biochem; 2005 Oct; 345(1):96-101. PubMed ID: 16125122
[TBL] [Abstract][Full Text] [Related]
15. Three active forms of aspartic proteinase from Mason-Pfizer monkey virus.
Zábranský A; Andreánsky M; Hrusková-Heidingsfeldová O; Havlícek V; Hunter E; Ruml T; Pichová I
Virology; 1998 Jun; 245(2):250-6. PubMed ID: 9636364
[TBL] [Abstract][Full Text] [Related]
16. Amino acid residues in the cytoplasmic domain of the Mason-Pfizer monkey virus glycoprotein critical for its incorporation into virions.
Song C; Micoli K; Bauerova H; Pichova I; Hunter E
J Virol; 2005 Sep; 79(18):11559-68. PubMed ID: 16140733
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the Basic Region of the Mason-Pfizer Monkey Virus Nucleocapsid Protein Affect Reverse Transcription, Genomic RNA Packaging, and the Virus Assembly Site.
Dostálková A; Kaufman F; Křížová I; Kultová A; Strohalmová K; Hadravová R; Ruml T; Rumlová M
J Virol; 2018 May; 92(10):. PubMed ID: 29491167
[TBL] [Abstract][Full Text] [Related]
18. Expression of simian type D retroviral (Mason-Pfizer monkey virus) capsids in insect cells using recombinant baculovirus.
Sommerfelt MA; Roberts CR; Hunter E
Virology; 1993 Jan; 192(1):298-306. PubMed ID: 8517023
[TBL] [Abstract][Full Text] [Related]
19. Structure of the Rhizomucor miehei aspartic proteinase complexed with the inhibitor pepstatin A at 2.7 A resolution.
Yang J; Quail JW
Acta Crystallogr D Biol Crystallogr; 1999 Mar; 55(Pt 3):625-30. PubMed ID: 10089458
[TBL] [Abstract][Full Text] [Related]
20. Atomic resolution crystal structure of Sapp2p, a secreted aspartic protease from Candida parapsilosis.
Dostál J; Pecina A; Hrušková-Heidingsfeldová O; Marečková L; Pichová I; Řezáčová P; Lepšík M; Brynda J
Acta Crystallogr D Biol Crystallogr; 2015 Dec; 71(Pt 12):2494-504. PubMed ID: 26627656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
